In the course of primary infection with herpes simplex virus 1 (HSV-1), children with inborn errors of toll-like receptor 3 (TLR3) immunity are prone to HSV-1 encephalitis (HSE) 1-3 . We tested the hypothesis that the pathogenesis of HSE involves nonhaematopoietic CNS-resident cells. We derived induced pluripotent stem cells (iPSCs) from the dermal fibroblasts of TLR3-and UNC-93B-deficient patients and from controls. These iPSCs were differentiated into highly purified populations of neural stem cells (NSCs), neurons, astrocytes and oligodendrocytes. The induction of interferon-b (IFN-b) and/or IFN-l1 in response to stimulation by the dsRNA analogue polyinosinic:polycytidylic acid (poly(I:C)) was dependent on TLR3 and UNC-93B in all cells tested. However, the induction of IFN-b and IFN-l1 in response to HSV-1 infection was impaired selectively in UNC-93B-deficient neurons and oligodendrocytes. These cells were also much more susceptible to HSV-1 infection than control cells, whereas UNC-93B-deficient NSCs and astrocytes were not. TLR3-deficient neurons were also found to be susceptible to HSV-1 infection. The rescue of UNC-93B-and TLR3deficient cells with the corresponding wild-type allele showed that the genetic defect was the cause of the poly(I:C) and HSV-1 phenotypes. The viral infection phenotype was rescued further by treatment with exogenous IFN-a or IFN-b ( IFN-a/b) but not IFN-l1. Thus, impaired TLR3-and UNC-93B-dependent IFN-a/b intrinsic immunity to HSV-1 in the CNS, in neurons and oligodendrocytes in particular, may underlie the pathogenesis of HSE in children with TLR3-pathway deficiencies.
HSV-1 produces double-stranded (dsRNA) during its replication 10, 11 and the dsRNA-sensing TLR3 is expressed and functional in non-haematopoietic (neurons, astrocytes, oligodendrocytes) and haematopoietic (microglia) CNS-resident cells, which produce IFN-b and IFN-l in response to TLR3 stimulation [12] [13] [14] [15] and can be infected with HSV-1 in vitro 13, [16] [17] [18] [19] . We therefore surmised that the pathogenesis of HSE in patients with TLR3-pathway deficiencies may involve impaired TLR3-dependent IFN-a/b and/or IFN-l immunity to HSV-1 in the CNS.
We tested this hypothesis by generating induced pluripotent stem cells (iPSCs) from control, UNC-93B-and TLR3-deficient dermal fibroblasts ( Supplementary Table 1 ). We first derived and fully characterized iPSC lines from a healthy child, from an HSE child with autosomal-recessive complete UNC-93B deficiency 1 , and from a patient with autosomal-recessive complete TLR3 deficiency 2 , by reprogramming primary dermal fibroblasts, as described previously 20 ( Supplementary  Fig. 1 and Methods). A robust stemness and pluripotency profile, karyotypic integrity and patient-specific origin of the iPSCs were confirmed ( Supplementary Fig. 1 ). Whole-exome sequencing for one control, one TLR3-deficient and two UNC-93B-deficient iPSC lines revealed more than 99.9% concordance with the corresponding parental fibroblast lines, in terms of exonic genetic variability ( Supplementary Table 2 ). No synonymous or non-synonymous germline and somatic rare variants of any of the 21 known TLR3-pathway genes were found in parental fibroblast and iPSC lines, respectively ( Supplementary Table 3 ). We also used two additional, previously described healthy control iPSC lines 21, 22 for subsequent experiments ( Supplementary Table 1 ).
We next induced the differentiation of iPSCs into all major nonhaematopoietic CNS-resident cells, including neural stem cells (NSCs), neurons, oligodendrocytes and astrocytes 23, 24 . The selective derivation of each individual neural lineage required a multistep iPSC-differentiation approach combined with fluorescence-activated cell sorting (FACS)mediated cell purification (Fig. 1a ). Neural differentiation of UNC-93B-deficient iPSCs, TLR3-deficient iPSCs, control iPSCs and control human embryonic stem cells (hESCs) (H9 line) was induced by dual SMAD inhibition 21, 24 (Fig. 1a and Supplementary Fig. 2a ). The resulting polarized columnar neuroepithelial structures expressed PLZF, ZO1 and PAX6, well-known markers of neural rosettes 23 . Mechanically passaged rosettes retained expression of the forebrain marker FOXG1 ( Fig. 1b ) and yielded neural precursor cells (NPCs) in the presence of FGF2 and EGF ( Fig. 1b and Supplementary Fig. 2a ). Through differential growth-factor treatment and the use of cell-type-specific surface markers in NPC-stage cells, we were able to isolate highly enriched populations of NSCs, neurons, astrocytes or oligodendrocyte lineage cells ( Fig. 1c and Supplementary Fig. 2b, c) .
The purified hESC-and iPSC-derived neuronal populations expressed additional lineage-specific markers ( Supplementary Fig. 3a ) and showed the electrophysiological properties of functional neurons ( Supplementary Fig. 3b-e ). The identity of the purified glial fibrillary acidic protein (GFAP)-expressing and O4-antigen-expressing glial cell populations was confirmed by global gene expression profiling ( Supplementary Fig. 4a, b ). Immunocytochemistry for stage-specific markers was used to identify the purified O4 'oligodendrocytes' used throughout this study as a mostly immature (pre-myelinating) oligodendrocyte population ( Supplementary Fig. 4c -e, Supplementary  Table 4 ). Quantitative analysis showed that our preparations of NSCs, neurons, astrocytes and oligodendrocytes were highly pure (Fig. 1d ), and similar gene-expression profiles were obtained for neurons and astrocytes derived from disease-specific and control cell lines ( Supplementary Fig. 5 ). Our in vitro CNS cell-differentiation system therefore constitutes a reliable platform for the comparative assessment of CNS cell-specific antiviral immunity.
TLR3 expression has been documented in neurons derived in vitro from a human teratocarcinoma cell line 13 , and in primary cells, either in human brain tissues in situ (neurons 25 ) or isolated from human brain ex vivo (oligodendrocytes and astrocytes 12, 14, 26 ), but not in human NSCs (self-renewing, multipotent cells responsible for generating neurons, astrocytes and oligodendrocytes in the CNS) 27 . We detected messenger RNA for key genes of the TLR3-responsive pathway, including TLR3 and UNC93B1, in all four cell types tested (Supplementary Fig. 6a-d ), whether differentiated from iPSCs or hESCs. We also detected mRNAs for genes encoding key molecules in the IFNresponsive pathways, including the receptors for IFN-a/b and IFN-l, in these cells ( Supplementary Fig. 6e -h). Levels of mRNA for the TLR3-and IFN-responsive pathway genes tested were similar, for each CNS cell type, between cells differentiated from control iPSCs, control hESCs and UNC-93B-deficient iPSCs, with the expected exception of UNC93B1, for which mRNA levels were lower in UNC-93B-deficient cells ( Fig. 2a and Supplementary Fig. 6a-d) .
We then studied TLR3 responses in the same cells. IFN-l1 and IFNb were induced in a time-dependent manner, by stimulation with the non-specific TLR3 agonist poly(I:C), a dsRNA analogue, in NSCs, 
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neurons, oligodendrocytes and astrocytes differentiated from healthy control iPSCs or hESCs, but not in UNC-93B-deficient iPSCdifferentiated CNS cells ( Fig. 2b-d and Supplementary Fig. 6i -l). The induction of NF-kB1, a key IFN-inducing molecule, and that of MX1, a key IFN-inducible molecule, were both impaired in UNC-93B-deficient oligodendrocytes after poly(I:C) stimulation ( Supplementary Fig.  6m , n). The impaired response to poly(I:C) in UNC-93B-deficient CNS cells was consistent with our previous data for UNC-93B-deficient fibroblasts, pointing to a TLR3-dependent response to dsRNA in these cell types 1 . Moreover, impaired poly(I:C) responsiveness in UNC-93Bdeficient neurons, oligodendrocytes and astrocytes was rescued by transient expression of the human UNC93B1 gene ( Fig. 2b-d) . Thus, the UNC-93B-dependent TLR3 pathway is functional in control human iPSC-derived NSCs, neurons, astrocytes and oligodendrocytes, at least for the induction of antiviral IFN-l1 and IFN-b in response to poly(I:C).
We thus set out to compare the response to HSV-1 in UNC-93Bdeficient and control iPSC or hESC-derived CNS cells after infection with HSV-1 and HSV-1-GFP (green fluorescent protein) 28 . Human NSCs and astrocytes seemed to be more susceptible to HSV-1 infection than neurons and oligodendrocytes, as massive HSV-1-GFP replication was observed earlier ( Supplementary Fig. 7 and data not shown). UNC-93B-deficient NSCs and astrocytes derived from two different iPSC lines also showed high levels of HSV-1-GFP replication, similar to those observed in the corresponding cell types derived from two control iPSC lines and the control hESC line (Fig. 3a-c and Supplementary Figs 8a-c and 9a-c). Treatment of UNC-93B-deficient and control NSCs and astrocytes with recombinant IFN-a2B or IFN-b, but not IFN-l1, decreased HSV-1-GFP replication levels ( Supplementary  Figs 8a , c-f and 9a, c-g). Moreover, treatment with poly(I:C) decreased HSV-1-GFP replication levels in control, but not in UNC-93Bdeficient astrocytes ( Supplementary Figs 9f and 10a-d ). By contrast, treatment with agonists of TLR9 (CpG-A or CpG-C) did not have such an effect ( Supplementary Fig. 10a-d) .
When UNC-93B-deficient neurons from the two UNC-93B-deficient iPSC lines were infected with HSV-1-GFP, HSV-1-GFP replication was faster, reaching higher levels than in neurons differentiated from four control iPSC lines or one hESC line ( Fig. 3a, d , e and Supplementary Fig. 11a ). The treatment of UNC-93B-deficient neurons with IFN-a2B or IFN-b, but not IFN-l1, rescued this phenotype ( Supplementary Fig. 11a ). Similar results were obtained with TLR3deficient neurons that had been differentiated from TLR3-deficient iPSCs 3,20 ( Fig. 3e and Supplementary Fig. 11b ). The phenotype of enhanced HSV-1 replication in UNC-93B-and TLR3-deficient neurons was rescued by expression of the wild-type human UNC93B1 and TLR3 genes, respectively ( Fig. 3f and Supplementary Fig. 11b ). Finally, higher levels and faster replication of HSV-1-GFP were also observed in UNC-93B-deficient oligodendrocytes than in oligodendrocytes differentiated from control iPSCs or hESCs, and this phenotype was rescued by treatment with IFN-a2B or IFN-b, but not IFN-l1 ( Fig. 3a, g and Supplementary Fig. 11c, d ). This is consistent with our previous finding of high susceptibility to HSV-1 and VSV in fibroblasts with TLR3-pathway deficiencies, associated with an impairment of the TLR3-dependent induction of IFN-b and IFN-l, which can be rescued more effectively by exogenous IFN-a/b than by IFN-l1 (refs 1-3).
We studied further the production of IFNs and inflammatory cytokines in UNC-93B-deficient and control CNS cells after infection with HSV-1. UNC-93B-deficient neurons, astrocytes and oligodendrocytes produced normal amounts of interleukin-6 (IL-6), as shown by comparison with control iPSC-or hESC-differentiated CNS cell types ( Supplementary Fig. 12a-c) . UNC-93B-deficient NSCs and astrocytes seemed to produce detectable but lower levels of IFN-l1 than the control cells tested ( Supplementary Fig. 12d, e ), suggesting that UNC-93B-independent, TLR3-independent partially compensatory pathways may be involved in triggering IFN responses to HSV-1 in human NSCs and astrocytes. The induction of IFN-b or IFN-l1 was readily observed in control iPSC-or hESC-differentiated neurons or oligodendrocytes, but was greatly impaired in UNC-93B-deficient neurons and oligodendrocytes, respectively ( Supplementary Fig. 12f , g). The induction of MX1 was also impaired in UNC-93B-deficient oligodendrocytes after HSV-1 infection ( Supplementary Fig. 12h ). Thus, neurons and oligodendrocytes lacking UNC-93B may be highly vulnerable to HSV-1 infection because of an impairment of the cell-autonomous IFN-a/b or IFN-l immunity.
Our findings suggest that neurons and oligodendrocytes provide strong, intrinsic protective anti-HSV-1 immunity in the CNS, through an intact TLR3 pathway. Although NSCs and astrocytes lacking UNC-93B are not more susceptible to HSV-1 infection than control cells in vitro, they may have a role in protective anti-HSV-1 immunity in the CNS in vivo. Indeed, mouse astrocytes rely on TLR3 to control HSV-2 (ref. 29 ). Haematopoietic cell-derived microglial cells, which also 
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express TLR3 and can be infected with HSV-1 (refs 12, 14, 17) , may also contribute to HSE. CNS-intrinsic mechanisms are thus vital for the control of HSV-1 in the course of primary infection in childhood. These new findings add to our previous results that indicated that most leukocytes and keratinocytes from HSE patients with TLR3-pathway deficiencies respond normally to stimulation with poly(I:C) or HSV-1 (refs 2, 3 and 9), and are consistent with the CNS-restricted pattern of lesions during childhood HSE, with no disseminated disease. Human non-haematopoietic cells may be the key to survival during the course of primary infection, extending the concepts of host defence beyond innate and adaptive haematopoietic immunity, to non-haematopoietic 'intrinsic' immunity 30 .
METHODS SUMMARY
Human iPSC generation. Fibroblasts from patients or controls were transduced with the polycistronic stem cell cassette (STEMCCA) lentiviral vector and cultured in DMEM medium supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, penicillin (50 U ml 21 ) and streptomycin (50 mg ml 21 ) as described previously 20 . After 72 h, cells were transferred onto irradiated mouse embryonic fibroblasts (iMEFs) and the medium was replaced with hESC medium. iPSC colonies with an ESC-like morphology were mechanically isolated 4 to 5 weeks after infection. Neural differentiation. We adapted previously described protocols for neural differentiation 21, 23 . Rosettes were collected on day 8 and cultured further to give clusters of proliferating NPCs. nestin 1 /TUJ1 2 NSCs were maintained in N2 medium supplemented with epidermal growth factor (EGF) (20 ng ml 21 ) and fibroblast growth factor 2 (FGF2) (20 ng ml 21 ) (R&D Systems) and B-27 supplement (1:100, Invitrogen) and sorted for EGF-receptor (EGFR) expression. Nestin 2 /TUJ1 1 neurons were obtained by eliminating EGFR 1 NSCs and CD44 1 non-neural cells from NPCs. For the generation of astrocytes, NPCs were allowed to proliferate in the presence of EGF and FGF2 for 40 to 60 days and were then cultured in medium containing 5% FBS for an additional 15 to 20 days. Immature oligodendrocytes were obtained from NPCs following treatment with SonicC25II (125 ng ml 21 ), FGF8 (100 ng ml 21 ; R&D Systems), brain-derived neurotrophic factor (BDNF) (20 ng ml 21 ) and ascorbic acid (0.2 mM) for 50 to 70 days and sorted for O4. TLR3 agonists and viral stimulation. A synthetic analogue of dsRNA, (polyinosinic:polycytidylic acid (poly(I:C)); Amersham), a TLR3 agonist, was used at a concentration of 25 mg ml 21 , for 2, 4 or 6 h of stimulation. For HSV-1 infection, we used the KOS-1 strain of HSV-1 and a GFP-expressing HSV-1 (HSV-1-GFP 28 ), at various multiplicities of infection (MOIs), to infect CNS cells. The induction of IFN-b, IFN-l and IFN-responsive genes was assessed in these cells, by quantifying mRNA by quantitative polymerase chain reaction with reverse transcription (RT-qPCR).
Full Methods and any associated references are available in the online version of the paper. 
HSV-1-GFP measurement HSV-1-GFP measurement oligodendrocytes. Infection with HSV-1-GFP for 24 h, at a multiplicity of infection of 1, was carried out. a, GFP expression in CNS cells differentiated from UNC93B1 2/2 iPSCs or from hESCs from a healthy control (C 1 ) was visualized using fluorescence microscopy. Phase-contrast photomicrographs from the same view are also shown. b-d GFP expression in NSCs (b), astrocytes (c) and neurons (d) differentiated from UNC93B1 2/2 iPSCs, from hESCs from a healthy control (C 1 (hESC)) and one to two iPSC lines each from up to three healthy controls (C 1 (iPSC)), was assessed with a fluorescence plate reader. The difference in GFP intensity between HSV-1-GFP-infected cells and uninfected cells is shown. e, GFP expression in neurons differentiated from two lines (C and H) of UNC93B1 2/2 iPSCs, one line of TLR3 2/2 iPSCs, a total of four iPSC lines from three healthy controls, one or two lines from each, or from one C 1 hESCs line.
f, GFP expression, in neurons from one C 1 iPSC line, in UNC93B1 2/2 neurons, without lentiviral infection, or after infection with a lentivirus containing human wild-type UNC93B1 (UNC93B1 2/2 1 UNC93B1) or a mock construct (UNC93B1 2/2 1 mock). g, GFP expression in oligodendrocytes differentiated from UNC93B1 2/2 iPSCs, from a C 1 hESC line and a C 1 iPSC line. Error bars, s.e.m., calculated from two to three experiments, from the C 1 hESC lines, the C 1 iPSC lines and the UNC93B1 2/2 lines, each studied in triplicate (bd, e and g); or from one experiment carried out in triplicate, representative of two independent experiments (f). ANOVA was performed for the HSV-1-GFP levels shown in b to g. When significant, Dunnett's t-tests were performed for two-bytwo comparisons. *P , 0.05, **P , 0.01, ***P , 0.001 (comparisons between each control line and each patient line).
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METHODS
Cell culture. Fibroblasts obtained from an UNC-93B-deficient patient, a TLR3deficient patient and a healthy control were maintained in DMEM medium supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, penicillin (50 U ml 21 ) and streptomycin (50 mg ml 21 ). The patients resided in France, where they were followed up and where informed consent was obtained, in accordance with local regulations, with institutional review board (IRB) approval. The experiments described here were conducted in the United States, in accordance with local regulations and with the approval of the IRB of the Rockefeller University, the Harvard Medical School and the Sloan-Kettering Institute for Cancer Research. Induced pluripotent stem cells (iPSCs) and human embryonic stem cells (hESCs; line H9 (WA-09, XX, P40-55) were maintained on CF1-irradiated MEFs (iMEFs, Globalstem) in hESC medium consisting of DMEM with Ham's F12 (Invitrogen) supplemented with 20% Knockout Serum (KOSR, Invitrogen), 10 ng ml 21 basic fibroblast growth factor (bFGF, Gemini Bio-Products), 1 mM L-glutamine (Invitrogen), 100 mM non-essential amino acids, 100 mM 2-b-mercaptoethanol (Sigma-Aldrich), penicillin (50 U ml 21 ) and streptomycin (50 mg ml 21 ). iPSCs were stimulated to differentiate into embryoid bodies by culture in bFGF-free hESC medium, without co-culture with feeder cells, on non-adherent Petri dishes, as described previously 31 . Neural induction and neural subtype specification. MS5 stromal cells were grown in MEM medium supplemented with 10% FBS and 2 mM L-glutamine 32 . The neural differentiation of hESCs and iPSCs was induced as described previously 33 , but in the presence of Noggin (R&D Systems) and SB431542 (Stemgent) from days 3 to 10 of differentiation (dual-SMAD inhibition 21 ), to increase the efficiency of rosette formation. Rosettes were collected mechanically, starting at day 8 of differentiation, and were re-plated under feeder-free conditions on dishes coated with 10 mg ml 21 polyornithine (Sigma), 2 mg ml 21 laminin (Cultrex) and 1 mg ml 21 fibronectin (Fisher), in N2 medium supplemented with Sonic C25 II (20 mg ml 21 ; R&D Systems), ascorbic acid (0.2 mM; Sigma) and BDNF (20 ng ml 21 ; R&D Systems). Rosettes were allowed to proliferate for a further 5 days and were then re-plated, dissociated in Ca 2 -and Mg 2 -free Hank's balanced salt solution (HBSS) and re-plated again. Emerging clusters of NPCs were collected for further proliferation or neural subtype specification. For the generation of neural stem cells and neurons, NPCs were maintained in N2 medium supplemented with EGF (20 ng ml 21 ) and FGF2 (20 ng ml 21 ; R&D Systems) and B-27 supplement without vitamin A (1:100; Invitrogen). For the generation of astrocytes, NPCs were allowed to proliferate and were passaged in the presence of EGF and FGF2 for 40 to 60 days and then exposed to N2 medium containing 5% FBS for an additional 15 to 20 days. For the generation of oligodendrocytes, emerging clusters of NPCs were cultured in N2 medium supplemented with Sonic C25II (125 ng ml 21 ), FGF8 (100 ng ml 21 ; R&D Systems), BDNF (20 ng ml 21 ) and ascorbic acid (0.2 mM) for 50 to 70 days. Plasmids and vectors. The polycistronic lentiviral pHAGE-STEMCCA-LoxP vector, carrying the OCT4, SOX2, KLF4 and C-MYC reprogramming factor genes, has been described elsewhere 34 . Human UNC93B1 complementary DNA was amplified from existing cDNA sequences with the following primers: forward 59-ATAATATGGCCACACATATGGAGGCGGAGCCG-39 and reverse 59-GTTGATTAGGATCTATCGTCACTGCTCCTCCGG-39. The amplified product was inserted downstream from the internal ribosome entry site (IRES) in a pHAGE2-EF1a-DsRedExpress-IRES-W lentiviral vector (available from the Mostoslavsky laboratory), with the In-Fusion Advantage PCR cloning Kit (Clontech). Lentivirus production. Lentiviruses containing STEMCCA or pHAGE2-EF1a-DsRedExpress-IRES-UNC93B1 were produced with a five-plasmid transfection system, in 293T packaging cells, by a slightly modified version of a method described previously 35 . In brief, 293T cells were transfected with STEMCCA or pHAGE2-EF1a-DsRedExpress-IRES-UNC93B1 and four plasmids encoding the packaging proteins Gag-Pol, Rev, Tat and the G protein of the vesicular stomatitis virus (VSVG), in the presence of the Trans-IT 293 transfection reagent (Mirus). Viral supernatants were collected every 12 h, on 2 consecutive days, starting 48 h after transfection, and viral particles were concentrated by ultracentrifugation at 49,000g for 1.5 h at 4 uC. Lentiviral infection and human iPSC generation. We infected 10 5 fibroblasts derived from patients or controls with the concentrated polycistronic STEMCCA lentiviral vector and then cultured them at 37 uC, under an atmosphere containing 5% CO 2 , in 2 ml of hFib medium supplemented with 5 mg ml 21 protamine sulphate, for 24 h. One day after infection, the viral supernatant was removed and the cells were cultured for 72 h in hFib medium. They were then transferred onto iMEFs and the medium was replaced with hESC medium. iPSC colonies with an ESC-like morphology were mechanically isolated 4 to 5 weeks after infection. Immunostaining. Cells were fixed by incubation in 4% paraformaldehyde for 30 min and permeabilized by incubation with 0.2% Triton X-100 for 30 min. Cells were stained in blocking buffer (3% BSA; 5% goat serum) with primary (or conjugated) antibodies at 4 uC overnight, washed and stained with secondary antibodies and 1 mg ml 21 Hoechst 33342 in blocking buffer for 3 h at 4 uC, in the dark. Primary OCT4 and NANOG antibodies (Abcam) were used at a concentration of 0.5 mg ml 21 , and an Alexa Fluor 555-conjugated anti-rabbit IgG 555 (Invitrogen) was used as the secondary antibody (1:2000). The following conjugated antibodies-TRA-1-60-Alexa Fluor 647, TRA-1-81-Alexa Fluor 488, SSEA-4-Alexa Fluor 647, and SSEA-3-Alexa 488 (Millipore)-were used at a dilution of 1:100. FoxG1 antibody was a gift from S. A. Anderson. Nestin antibody was obtained from Neuromics, TUJ1antibody from Covance, O4 from Millipore, GFAP from Dako, PLZF from Calbiochem, and ZO1 from Zymed. Images were acquired with a Pathway 435 bioimager equipped with a 310 objective (BD Biosciences). Whole-exome sequencing and analysis. DNA (3 mg) was extracted from cells and sheared with a Covaris S2 Ultrasonicator (Covaris). An adaptor-ligated library was prepared with the TruSeq DNA Sample Prep Kit (Illumina). Exome capture was carried out with the SureSelect Human All Exon 50 Mb kit (Agilent Technologies). Paired-end sequencing was performed on an Illumina HiSeq 2000 (Illumina), generating 100-base reads. The sequences were aligned with the human genome reference sequence (hg19 build) using the BWA aligner 36 . Downstream processing was carried out with the Genome Analysis Toolkit (GATK) 37 , SAM tools 38 and Picard Tools (http://picard.sourceforge.net). Variant calls were made with GATK UnifiedGenotyper. All calls with a Phred-scaled SNP quality of #20 were filtered out. GATK VariantEval was used to compare the call sets for fibroblasts and iPSCs. FACS-mediated cell purification. Cells were dissociated with Accutase (Innovative Cell Technologies) and subjected to FACS with O4 (1:300; Millipore), CD44 FITC (2 ml per 10 6 cells; Abcam), and EGFR PE (10 ml per 10 6 cells; Abcam) antibodies, on a FACS Aria II machine (BD). Karyotype analysis. Karyotyping and G-banding were carried out blind, by Cell Line Genetics. Mutation analysis. Whole-genome DNA was isolated from fibroblasts and iPSCs with the QiAMP DNA Kit (Qiagen). Exon 8 of the UNC93B1 gene was amplified with the forward primer GCGTGGCTTTGTGCTGAGAG and the reverse primer CAGGAGGGGGATATTTGGGA. Reaction products were purified with the QIAquick PCR purification kit (Qiagen) and sequenced by the DF/HCC DNA Sequencing Facility. The results were analysed with Sequencher 4.8 software (Gene Codes Corporation). Microarray analysis. Total RNA was extracted with Trizol reagent (Invitrogen). RNA was collected from astrocytes and from CD44 2 /EGFR 2 neurons differentiated from control hESCs or UNC-93B-deficient iPSCs. The RNA was then processed by the MSKCC Genomic core facility and hybridized with Illumina human HT-12 oligonucleotide arrays. Gene-expression analysis was carried out with the Partek Genomics Suite: following quantile normalization, all the genes displaying differential expression (FDR of 0.05, fold change of at least 62) with respect to hESC (total of 7,210 genes) in each population were visualized by clustering. Raw data for the microarray analyses performed in this study are available from the public repository of GEO Data Sets (accession number GSE40593). Electrophysiology. Whole-cell current clamp recordings were performed at room temperature (23-24 uC) in a Multiclamp 700B amplifier (Molecular Devices), as described previously 39, 40 . Neurons were identified under a Nikon microscope equipped with a 34 objective and a 340 water-immersion objective. Cells were continuously perfused with freshly prepared extracellular solution containing 126 mM NaCl, 26 mM NaHCO 3 , 3.6 mM KCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 2 mM CaCl 2 and 17 mM glucose, and the solution was saturated with 95% O 2 and 5% CO 2. The intracellular solution contained 135 mM potassium gluconate, 5 mM NaCl, 10 mM HEPES, 0.5 mM EGTA, 3 mM potassium ATP, 0.2 mM sodium guanosine triphosphate (GTP) and 10 mM sodium phosphocreatine. The pH was adjusted to 7.3 with KOH, and the osmolarity of the solution was approximately 290 milliosmoles (mOsm). Input resistance was calculated from the voltage response elicited by the intracellular injection of a depolarizing (110-or 120-pA) current pulse. Current steps were applied for 1 s to evoke action potentials. Liquid junction potentials were calculated and corrected off-line. Data were analysed with Clampfit (Molecular Devices) and SigmaPlot 11 (Systat Software) and are presented as means 6 s.e.m. Quantitative PCR with reverse transcription. For analysis of the expression profiles of key genes involved in stem cell properties and pluripotency, total RNA was extracted with the mirVana RNA isolation kit (Ambion). We reversetranscribed 100 ng of total RNA to generate cDNA, in qScript cDNA Supermix (Quanta). RT-qPCR was then performed in an AB 7500 Real-Time PCR system (Applied Biosystems), with the PowerSYBR Green PCR Master Mix (Applied Biosystems). The results were analysed with SDSv1 Software and normalized with respect to b-actin gene expression. Expression levels were determined by relative RESEARCH LETTER
